Apimeds Pharmaceuticals US (APUS) Prepaid Assets (2023 - 2025)

Apimeds Pharmaceuticals US's Prepaid Assets history runs 3 years deep, the most recent figure standing at $48500.0 for Q4 2025.

• Quarterly Prepaid Assets rose 405.1% year-over-year to $48500.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $48500.0 (up 405.1% YoY) and the FY2025 annual result came in at $48500.0, up 405.1% from the prior year.
• Prepaid Assets was $48500.0 for Q4 2025 at Apimeds Pharmaceuticals US, down from $344990.0 in the prior quarter.
• Across five years, Prepaid Assets topped out at $1.6 million in Q2 2025 and bottomed at $9562.0 in Q1 2025.
• A 3-year average of $339745.8 and a median of $30047.5 in 2023 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2024 — Prepaid Assets decreased 17.19% — and 2025, when it soared 405.1%.
• Apimeds Pharmaceuticals US's Prepaid Assets stood at $11595.0 in 2023, then dropped by 17.19% to $9602.0 in 2024, then surged by 405.1% to $48500.0 in 2025.
• Business Quant data shows APUS's Prepaid Assets at $48500.0 in Q4 2025, $344990.0 in Q3 2025, and $1.6 million in Q2 2025.